Hematologic Malignancies Clinical Trials

182 clinical trials for Hematologic Malignancies across international registries, including 36 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics — RECRUITING · NA
• Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ... — RECRUITING · PHASE1
• Tempus Open Link for Individual Voices in Innovative Analytics Registry: Platform Protocol for Multimodal Real-World Evidence in Cancer — RECRUITING
• A Phase 1 Study of IM-1021 in Participants With Advanced Cancer — RECRUITING · PHASE1
• Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax — RECRUITING
• Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003) — RECRUITING · PHASE2
• A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies — RECRUITING · PHASE1
• Post-Transplant Cyclophosphamide in Patients Aged >/= 65 Years Undergoing Haploidentical Transplant — RECRUITING · PHASE1
• Phase I Trial Integrating HLA-Haploidentical Anti-CD19 CAR-T Cells With Post-Transplantation Cyclophosphamide-Based HLA-Haploidentical Hematopoietic Cell Transplantation — RECRUITING · PHASE1
• PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV) — RECRUITING · PHASE2
• Gene Therapy Follow-up Protocol for People Previously Enrolled in CAR-T Cell Studies — RECRUITING
• Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587) — RECRUITING · PHASE3
• Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML — RECRUITING · PHASE1
• Prophylactic TCRaB+ and CD19+ Depleted Donor Lymphocyte Infusion After Allogeneic Stem Cell Transplant in High-Risk Patients With Hematologic Malignancies — RECRUITING · NA
• Follow-Up Evaluation for Gene-Therapy-Related Delayed Adverse Events After Participation in Pediatric Oncology Branch Clinical Trials — RECRUITING
• Leflunomide to Prevent Cytomegalovirus Reactivation in Stem Cell Transplant Patients — RECRUITING · PHASE2
• A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant — RECRUITING · PHASE2
• A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) — RECRUITING
• IVIG for Infection Prevention After CAR-T-Cell Therapy — RECRUITING · PHASE2
• A Study of BL-M24D1 in Patients With Relapsed or Refractory Multiple Myeloma and Other Hematologic Malignancies — RECRUITING · PHASE1
• Optimized Cord Blood Transplantation for the Treatment of Patients With High-risk Hematologic Malignancies Who Have Relapsed After First Allogeneic Stem Cell Transplantation — RECRUITING · PHASE2
• Allogeneic HSCT With Low-Dose Post-Transplant Cyclophosphamide for GVHD Prevention — RECRUITING · PHASE2
• Mayo Clinic Radiotherapy Patient Outcomes Registry and Biobanking Study — RECRUITING
• Aberrant Expression of CD56 in Patients With Hematologic Malignancies. — RECRUITING
• Study to Evaluate the Pharmacokinetics and Safety of Pralatrexate in Patients With Advanced Solid Tumor or Hematological Malignancy and Either Normal Hepatic Function or Mild, Moderate, or Severe Hepatic Impairment — RECRUITING · PHASE1
• Risk-ADAPTed Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation — RECRUITING · PHASE2
• This Study is a FIH Study Which is Required to Understand the PK Characteristics, MTD, RP2D and Safety Profile. — RECRUITING · PHASE1
• Digital Health Intervention for Self-Management and Telemonitoring in Chimeric Antigen Receptor (CAR-T) Therapy — RECRUITING · PHASE3
• Clinical Cohort of Lymphoma Patients in Malawi — RECRUITING
• Extension Study to Provide Continued Treatment for Patients With Hematologic Malignancies Previously Enrolled in Studies With Tafasitamab — RECRUITING · PHASE2
• ICP-248 in Combination With Orelabrutinib in Treatment-naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (APEX-03) — RECRUITING · PHASE2
• Follow-Up for Study Participants Treated With an Allogeneic CAR T-Cell Product — RECRUITING
• A Study to Assess the Effect of Venetoclax on Ethinyl Estradiol and Levonorgestrel in Female Participants With Different Hematological Malignancies — RECRUITING · PHASE1
• APG-2575 Study of Safety, Tolerability ,PK/PD in Patients With Hematologic Malignancies — RECRUITING · PHASE1
• Register of Blood Stem Cell Transplantation — RECRUITING
• Elderly CAncer Patient — RECRUITING
• Orca-T Expanded Access Program Study for Patients With Advanced Hematologic Malignancies — OTHER
• Rutgers University Study of the Genetics of Blood Cancers — NOT_YET_RECRUITING
• A Clinical Trial of MK-1045 in People With B-cell Cancer (MK-1045-006) — NOT_YET_RECRUITING · PHASE2
• Giving Chemotherapy for a Shortened Amount of Time Before a Stem Cell Transplantation — ACTIVE_NOT_RECRUITING · PHASE1
• Role of Viscoelastometric Testing in the Development and Validation of a Clinical-biological Score for Predicting Bleeding in Patients With Malignant Haematological Disorders and Severe Thrombocytopenia — NOT_YET_RECRUITING
• A Study of Teclistamab in Japanese Participants With Relapsed or Refractory Multiple Myeloma — COMPLETED · PHASE1
• Early Discontinuation of Antibiotics in Paediatric High-risk Febrile Neutropenia — NOT_YET_RECRUITING · PHASE4
• Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies With Alpha Beta TCell and B Cell Depletion Using the CliniMACS Device — ACTIVE_NOT_RECRUITING · PHASE2
• A Study to Evaluate Long-term Safety of CC-486 (Oral Azacitidine) in Subjects With Hematological Disorders — COMPLETED · PHASE2
• An Inpatient Advance Care Planning Intervention for Older Patients With Hematologic Malignancies — COMPLETED · NA
• A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Hematologic Malignancies — ACTIVE_NOT_RECRUITING · PHASE1
• Disease Burden Transition of Mucormycosis in Hematologic Malignancies Population Across Covid 19 Era: a Single-center Comparative Analysis From China — COMPLETED
• The Safety and Efficacy of the Regimen of Thiotepa + Fludarabine +Granulocyte Colony-Stimulating Factor+ Cytarabine + Busulfan in Single Unrelated Umbilical Cord Blood Transplantation — NOT_YET_RECRUITING · PHASE2
• Study of VIP152, Venetoclax, and Prednisone (VVIP) in Relapsed/Refractory Lymphoid Malignancies — COMPLETED · PHASE1

Refine this search